JP2013517300A5 - - Google Patents

Download PDF

Info

Publication number
JP2013517300A5
JP2013517300A5 JP2012549209A JP2012549209A JP2013517300A5 JP 2013517300 A5 JP2013517300 A5 JP 2013517300A5 JP 2012549209 A JP2012549209 A JP 2012549209A JP 2012549209 A JP2012549209 A JP 2012549209A JP 2013517300 A5 JP2013517300 A5 JP 2013517300A5
Authority
JP
Japan
Prior art keywords
hydrogen
pharmaceutical composition
alkyl
formula
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012549209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013517300A (ja
JP6232184B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2011/000051 external-priority patent/WO2011088504A1/en
Publication of JP2013517300A publication Critical patent/JP2013517300A/ja
Publication of JP2013517300A5 publication Critical patent/JP2013517300A5/ja
Application granted granted Critical
Publication of JP6232184B2 publication Critical patent/JP6232184B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012549209A 2010-01-19 2011-01-19 神経伝導速度改善のための方法および組成物 Expired - Fee Related JP6232184B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29637510P 2010-01-19 2010-01-19
US61/296,375 2010-01-19
PCT/AU2011/000051 WO2011088504A1 (en) 2010-01-19 2011-01-19 Methods and compositions for improved nerve conduction velocity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016073914A Division JP2016155846A (ja) 2010-01-19 2016-04-01 神経伝導速度改善のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2013517300A JP2013517300A (ja) 2013-05-16
JP2013517300A5 true JP2013517300A5 (cg-RX-API-DMAC7.html) 2014-02-27
JP6232184B2 JP6232184B2 (ja) 2017-11-15

Family

ID=44306296

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012549209A Expired - Fee Related JP6232184B2 (ja) 2010-01-19 2011-01-19 神経伝導速度改善のための方法および組成物
JP2016073914A Pending JP2016155846A (ja) 2010-01-19 2016-04-01 神経伝導速度改善のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016073914A Pending JP2016155846A (ja) 2010-01-19 2016-04-01 神経伝導速度改善のための方法および組成物

Country Status (10)

Country Link
US (1) US9095587B2 (cg-RX-API-DMAC7.html)
EP (1) EP2525795B1 (cg-RX-API-DMAC7.html)
JP (2) JP6232184B2 (cg-RX-API-DMAC7.html)
CN (2) CN102821765A (cg-RX-API-DMAC7.html)
AU (1) AU2011207104C1 (cg-RX-API-DMAC7.html)
CA (1) CA2787173C (cg-RX-API-DMAC7.html)
ES (1) ES2560327T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ601383A (cg-RX-API-DMAC7.html)
WO (1) WO2011088504A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201205375B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ605444A (en) * 2010-07-21 2015-06-26 Spinifex Pharm Pty Ltd Salt and solvates of a tetrahydroisoquinoline derivative
US10391331B2 (en) * 2011-03-29 2019-08-27 Biolyst, Llc. Systems and methods for use in treating sensory impairment
JP6232384B2 (ja) 2012-01-06 2017-11-15 ノバルティス アーゲー 複素環式化合物およびその使用方法
JP6258867B2 (ja) 2012-01-25 2018-01-10 ノバルティス アーゲー 複素環式化合物およびその使用方法
EP2807171B1 (en) * 2012-01-25 2020-08-12 Novartis AG Heterocyclic compounds and methods for their use
NZ630908A (en) * 2013-07-08 2017-08-25 Novartis Ag Heterocyclic compounds and methods of their use
CN107001337B (zh) 2015-01-13 2021-05-04 诺华股份有限公司 作为血管紧张素ii型拮抗剂的吡咯烷衍生物
ES2898635T3 (es) 2015-03-12 2022-03-08 Novartis Ag Compuestos heterocíclicos y métodos para su uso
CN106478502B (zh) * 2015-08-29 2021-04-27 上海翰森生物医药科技有限公司 1,2,3,4-四氢异喹啉衍生物、其制备方法和应用
KR102132761B1 (ko) * 2017-06-09 2020-07-17 산동 단홍 파머수티컬 컴퍼니., 리미티드. At2r 수용체 길항제로서의 카르복시산 유도체
CN112585120B (zh) * 2018-11-02 2022-11-11 山东丹红制药有限公司 一种血管紧张素ii受体2拮抗剂的盐型、晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091390A (en) * 1990-09-20 1992-02-25 E. I. Du Pont De Nemours And Company Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogs
HUT71331A (en) * 1992-04-13 1995-11-28 Zeneca Ltd Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
US5246943A (en) 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
US5236934A (en) 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
GB2337701A (en) * 1998-05-26 1999-12-01 United Medical And Dental Schools Of Guys St Thomas Hospitals Treatment of ischemia with an angiotensin II antagonist
NZ555334A (en) * 2004-12-24 2010-05-28 Spinifex Pharm Pty Ltd Method of treatment or prophylaxis of a neuropathic condition using AT2 receptor antagonist
JP5230595B2 (ja) * 2006-03-20 2013-07-10 スピニフェクス ファーマシューティカルズ ピーティーワイ リミテッド 炎症性疼痛の治療または予防の方法
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists

Similar Documents

Publication Publication Date Title
JP2017528507A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2017528503A5 (cg-RX-API-DMAC7.html)
JP2013523733A5 (cg-RX-API-DMAC7.html)
JP2012255002A5 (cg-RX-API-DMAC7.html)
DE602004010531D1 (de) Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
JP2015520151A5 (cg-RX-API-DMAC7.html)
JP2015512931A5 (cg-RX-API-DMAC7.html)
CN103781766A (zh) 用作鞘氨醇-1磷酸酯受体调节剂的取代的双环甲胺衍生物
JP2010522710A5 (cg-RX-API-DMAC7.html)
JP2016522254A5 (cg-RX-API-DMAC7.html)
JP2015502974A5 (cg-RX-API-DMAC7.html)
JP2011524850A5 (cg-RX-API-DMAC7.html)
JP2009511450A5 (cg-RX-API-DMAC7.html)
JP2005535592A5 (cg-RX-API-DMAC7.html)
JP2008519840A5 (cg-RX-API-DMAC7.html)
JP2019532926A5 (cg-RX-API-DMAC7.html)
RU2014113679A (ru) N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1
JP2015051983A5 (cg-RX-API-DMAC7.html)
JP2017511377A5 (cg-RX-API-DMAC7.html)
JP2016511260A5 (cg-RX-API-DMAC7.html)
WO2010020585A1 (en) Serotonin reuptake inhibitors for the treatment of rett syndrome
JP2015535247A5 (cg-RX-API-DMAC7.html)
JPWO2023195529A5 (cg-RX-API-DMAC7.html)
JP2017522300A5 (cg-RX-API-DMAC7.html)